Correction of an inflammatory process with an interleukin-1 inhibitor in the combination treatment of secondary osteoarthritis in the presence of comorbid condition


Cite item

Full Text

Abstract

Aim. To enhance the efficiency of treatment in patients with secondary osteoarthritis (ОА) in the presence of comorbid condition, by using an interleukin-1 inhibitor (IL-1i) and laser therapy (LT). Subjects and methods. A total of 248 patients aged 38 to 65 years with RA and secondary OA who had predominantly Stage II in accordance with the Disease Activity Score 28 (DAS28) were examined. According to the received therapy, the patients were divided into 4 groups: 1) IL-1i + LT + mrthotrexate (MT); 2) IL-1i + MT; 3) LT + MT; 4) MT. The efficiency of treatment was evaluated from changes in the KOOS (Knee injury and Osteoarthritis Outcome Score), DAS 28, IL-1, and cartilage oligomeric matrix protein (COMP) 6 months later. Results. There were statistically significant functional improvements in KOOS and DAS28 in Groups 1 and 2 patients with secondary OA in RA. Clinical efficacy was confirmed by positive changes in serum IL-1 and COMP levels. Conclusion. Incorporation of an IL-1i into a therapy regimen for secondary OA in RA patients during basic therapy could not only improve the functional status of patients, but also decrease activity of the underlying disease according to the DAS 28.

References

  1. Насонов Е.Л., Мазуров В.И., Каратеев Д.Е., Лукина Г.В., Жиляев Е.В., Амирджанова В.Н., Муравьев Ю.В., Чичасова Н.В. Проект рекомендаций по лечению ревматоидного артрита Общероссийской общественной организации «Ассоциация ревматологов России»-2014 (часть 1). Научно-практическая ревматология. 2014;5:477-494. doi: 10.14412/1995-4484-2014-477-494.
  2. Michaud K, Wolfe F. Comorbidities in rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 2007;21(5):885-906. doi: 10.1016/j.berh.2007.06.002.
  3. Никитина Н.М., Афанасьева И.А., Романова Т.А., Ребров А.П. Особенности коморбидности у больных ревматоидным артритом в разные годы наблюдения. Современная ревматология. 2015;1:39-43. doi: 10.14412/1996-7012-2015-1-39-41.
  4. Samson DJ, Grant MD, Ratko TA, Bonnell CJ, Ziegler KM, Aronson N. Treatment of primary and secondary osteoarthritis of the knee. AHRQ Publication; 2007:144.
  5. Pelletier JP, Mineau F, Fernandes JS. Diacerhein and Rhein reduce the IL-1β-stimulated inducible nitric oxide synthesis level and activity while stimulating cycloogenase-2 synthesis in human osteoarthritis chondrocytes. J Rheumatol. 1998;25:2417-2424.
  6. Hom JT. In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice. J Immunol. 1988;141:834-841.
  7. Балабанова Р.М. Роль интерлейкина-1 при остеоартрозе и возможности его блокирования. Современная ревматология. 2011;1:58-63. doi: 10.14412/1996-7012-2011-653.
  8. Балабанова Р.М., Алексеева Л.И. Ингибиция интерлейкина-1 — новый подход к лечению остеоартроза. Медицинский совет. 2010; 7-8:40-41.
  9. Jordan KM, Arden NK, Doherty M. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies, including Therapeutic Trials (ESCISIT). Annals of the Rheumatic Diseases. 2003;62:1145-1155. doi: 10.1136/ard.2003.011742.
  10. Москвин С.В., Буйлин В.А. Основы лазерной терапии. Тверь: Триада; 2006.
  11. Москвин С.В. Эффективность лазерной терапии. Москва; Тверь: Триада; 2014.
  12. Агаев Б.А., Гейниц А.В., Мамедов М.М. Руководство по эффективному использованию лазерных технологий в хирургии доброкачественной патологии печени и желчевыводящих путей. Баку: Kitab alem; 2010.
  13. Буйлин В.А. Магнитно-лазерная терапия заболеваний суставов и позвоночника. М.: Адвансед Солюшнз; 2011.
  14. Brosseau L, Welch V, Wells G, Tugwell P, Robert de Bie, Gam A, Harman K, Shea B, Morin M. Low level laser therapy for osteoarthritis and rheumatoid arthritis: a metaanalysis. Rheumatology. 2000;27:1961-1969.
  15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey L.A., Kaplan SR, Liang MH, Luthra HS. American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism. 1988;31:315-324. doi: 10.1002/art.1780310302.
  16. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League against Rheumatism collaborative initiative. Annals of the Rheumatic Diseases. 2010;69:1580-1588. doi: 10.1136/ard.2010.138461.
  17. Ревматология. Клинические рекомендации. Под ред. академика Насонова Е.Л. М.: ГЭОТАР-Медиа; 2010.
  18. Насонов Е.Л., Каратеев Д.Е., Чичасова Н.Е. Новые рекомендации по лечению ревматоидного артрита (EULAR 2013): место метотрексата. Научно-практическая ревматология. 2014;1:8-26. doi: 10.14412/1995-4484-2014-8-26.
  19. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, Maarten de Wit, Aletaha D, Betteridge N, Bijlsma J, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes J, Kouloumas M, Tore K Kvien, Mariette X, Pavelka K, Piet LCM van Riel, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, Désirée van der Heijde. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological diseases — modifying antirheumatic drugs: 2013 update. Annals of the Rheumatic Diseases. 2014;73:492-509. doi: 10.1136/annrheumdis-2013-204573.
  20. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D. Treating RA to target: recommendation of an international task force. Annals of the Rheumatic Diseases. 2010;69:631-637. doi: 10.1136/ard.2009.123919.
  21. Milenkovic M, Djordievic М. Efficiency of the intraarticular application of hyaluronic acid in the treatment of secondary osteoarthritis of the knee in patients with rheumatoid arthritis and in patients with primary osteoarthritis. Annals of the Rheumatic Diseases. 2012;71(3):695. doi: 10.1136/annrheumdis-2012-eular.991.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies